The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer.
Bellardita, L., Valdagni, R., Van Den Bergh, R., Randsdorp, H., Repetto, C., Venderbos, L., Lane, J., Korfage, I., How does active surveillance for prostate cancer affect quality of life? A systematic review, <<EUROPEAN UROLOGY>>, 2015; 67 (4): 637-645. [doi:10.1016/j.eururo.2014.10.028] [http://hdl.handle.net/10807/68070]
Autori: | |
Titolo: | How does active surveillance for prostate cancer affect quality of life? A systematic review |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.eururo.2014.10.028 |
Data di pubblicazione: | 2015 |
Abstract: | The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer. |
Lingua: | Inglese |
Rivista: | |
Citazione: | Bellardita, L., Valdagni, R., Van Den Bergh, R., Randsdorp, H., Repetto, C., Venderbos, L., Lane, J., Korfage, I., How does active surveillance for prostate cancer affect quality of life? A systematic review, <<EUROPEAN UROLOGY>>, 2015; 67 (4): 637-645. [doi:10.1016/j.eururo.2014.10.028] [http://hdl.handle.net/10807/68070] |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |